BACKGROUND: Previously, we have shown that endothelial microparticles (EMPs) injected into mice induce acute lung injury (ALI) [1]. In this study, we hypothesize that EMPs induce ALI by initiating cytokine release in the lung, leading to recruitment and activation of neutrophils. MATERIALS AND METHODS: C57BL/6J male mice (8-10 wk old) were intravenously injected with EMPs (200,000/mL), LPS (2 mg/kg), or both. Bronchoalveolar lavage (BAL) and serum levels of IL-1β and TNF-α were analyzed by enzyme-linked immunoassay (ELISA). Morphometric analysis was performed on H and E stained lung sections. Myeloperoxidase (MPO) levels were determined via an enzymatic assay and immunofluorescence of stained sections. RESULTS: EMPs led to significantly increased pulmonary and systemic IL-1β and TNF-α levels, which correlated with increased neutrophil recruitment to the lung. MPO levels in the lungs were increased significantly following injection of EMPs or LPS, compared to PBS. In mice treated with EMPs and LPS either simultaneously or successively, the cytokine and MPO levels were significantly increased over that of either treatment alone. CONCLUSION: EMPs contribute to lung injury through the initiation of a cytokine cascade that increases recruitment of neutrophils and subsequent release of MPO. Furthermore, treatment of mice with both EMPs and LPS induced greater lung injury than either treatment alone, suggesting that EMPs prime the lung for increased injury by other pathogens. Therapies aimed at reducing or blocking EMPs may be a useful strategy for attenuating lung injury.
BACKGROUND: Previously, we have shown that endothelial microparticles (EMPs) injected into mice induce acute lung injury (ALI) [1]. In this study, we hypothesize that EMPs induce ALI by initiating cytokine release in the lung, leading to recruitment and activation of neutrophils. MATERIALS AND METHODS: C57BL/6J male mice (8-10 wk old) were intravenously injected with EMPs (200,000/mL), LPS (2 mg/kg), or both. Bronchoalveolar lavage (BAL) and serum levels of IL-1β and TNF-α were analyzed by enzyme-linked immunoassay (ELISA). Morphometric analysis was performed on H and E stained lung sections. Myeloperoxidase (MPO) levels were determined via an enzymatic assay and immunofluorescence of stained sections. RESULTS: EMPs led to significantly increased pulmonary and systemic IL-1β and TNF-α levels, which correlated with increased neutrophil recruitment to the lung. MPO levels in the lungs were increased significantly following injection of EMPs or LPS, compared to PBS. In mice treated with EMPs and LPS either simultaneously or successively, the cytokine and MPO levels were significantly increased over that of either treatment alone. CONCLUSION: EMPs contribute to lung injury through the initiation of a cytokine cascade that increases recruitment of neutrophils and subsequent release of MPO. Furthermore, treatment of mice with both EMPs and LPS induced greater lung injury than either treatment alone, suggesting that EMPs prime the lung for increased injury by other pathogens. Therapies aimed at reducing or blocking EMPs may be a useful strategy for attenuating lung injury.
Authors: John C Densmore; Paul R Signorino; Jingsong Ou; Ossama A Hatoum; J Jordi Rowe; Yang Shi; Sushma Kaul; Deron W Jones; Robert E Sabina; Kirkwood A Pritchard; Karen S Guice; Keith T Oldham Journal: Shock Date: 2006-11 Impact factor: 3.454
Authors: J P Eiserich; M Hristova; C E Cross; A D Jones; B A Freeman; B Halliwell; A van der Vliet Journal: Nature Date: 1998-01-22 Impact factor: 49.962
Authors: Denise Lau; Hanke Mollnau; Jason P Eiserich; Bruce A Freeman; Andreas Daiber; Ursula M Gehling; Jens Brümmer; Volker Rudolph; Thomas Münzel; Thomas Heitzer; Thomas Meinertz; Stephan Baldus Journal: Proc Natl Acad Sci U S A Date: 2004-12-29 Impact factor: 11.205
Authors: Abdelali Agouni; Anne Hélène Lagrue-Lak-Hal; Pierre Henri Ducluzeau; Hadj Ahmed Mostefai; Catherine Draunet-Busson; Georges Leftheriotis; Christophe Heymes; Maria Carmen Martinez; Ramaroson Andriantsitohaina Journal: Am J Pathol Date: 2008-09-04 Impact factor: 4.307
Authors: Michael P Mohning; Stacey M Thomas; Lea Barthel; Kara J Mould; Alexandria L McCubbrey; S Courtney Frasch; Donna L Bratton; Peter M Henson; William J Janssen Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-09-21 Impact factor: 5.464